Axmed

We believe access to medicines should be equal for all. We bring an innovative marketplace to empower emerging markets to access medicines more competitively.

Imagine a world where critical medicines are within reach, affordable, and synonymous with quality, no matter where you are. That's the world we're building with our unique, demand-aggregation model that unites healthcare providers across LMICs. At the heart of our identity is a resolute commitment: to build a future where geography and income never stand between any individual and life-saving medicines. Our platform isn't merely a space for transactions, we unlock affordable access to medicines by aggregating demand across healthcare providers. We also help manufacturers build a sustainable and reliable global access strategy. Our business focuses on LMICs and strengthens the purchasing power of these markets to ensure the supply of cost-effective, high-quality medicines. We partner exclusively with authorized, high-quality pharmaceutical companies and certified caregivers to accelerate access to medicines.

03/27/2026

This week, our team was in Nairobi for the International Maternal and Newborn Health Conference (IMNHC), meeting with government leaders, pharmaceutical manufacturers, procurers, and partners for honest conversations on the future of medicines access across the region.

These conversations highlighted a central issue: the challenge with healthcare access isn’t supply. It’s coordination.

On Monday, we brought that conversation into focus at an event we hosted exploring how technology can change this. Through technology-enabled procurement, pricing becomes transparent, and supply chains become more reliable and responsive.

Speakers brought this to life with real examples, from reduced costs to faster access and stronger alignment across the ecosystem.

No single actor can solve this. But the model is working. The focus now is scaling it.

Thank you to everyone who joined us and contributed to an open, candid dialogue on what comes next.

03/24/2026

We’re honoured to have been named to Most Innovative Companies of 2026, ranked #2 in Healthcare globally! 🚀

We’re incredibly proud of this moment, and remain laser-focused on what comes next.

To our team, partners, and everyone building alongside us: thank you. We’re just getting started. 🎉

03/19/2026

Each year, hundreds of thousands of children across sub-Saharan Africa die from infections that are both preventable and treatable. Interventions like azithromycin distribution can significantly reduce child mortality in high-burden settings.

That’s why today, we’re announcing a $7 million supply agreement to support the delivery of quality-assured medicines through the Resiliency through Azithromycin for Children (REACH) programme in Burkina Faso.

Through the agreement, Axmed will support the country’s participation in the REACH programme, helping to expand coverage and reduce preventable child deaths.

𝗢𝘃𝗲𝗿 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝘁𝗵𝗿𝗲𝗲 𝘆𝗲𝗮𝗿𝘀, 𝘂𝗽 𝘁𝗼 𝟭𝟲 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗱𝗼𝘀𝗲𝘀 𝗼𝗳 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗲𝗱 𝘁𝗼 𝗰𝗵𝗶𝗹𝗱𝗿𝗲𝗻 𝘂𝗻𝗱𝗲𝗿 𝗳𝗶𝘃𝗲 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗰𝗼𝘂𝗻𝘁𝗿𝘆.

This is what country-led, system-enabled access looks like.

Read more at the link in our bio.

03/18/2026

𝗔𝘀 𝗼𝘂𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝘀𝗰𝗮𝗹𝗲𝘀, 𝘀𝗼 𝗱𝗼𝗲𝘀 𝘁𝗵𝗲 𝗯𝗲𝗵𝗶𝗻𝗱-𝘁𝗵𝗲-𝘀𝗰𝗲𝗻𝗲𝘀 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗱.

Our tech team is constantly working to solve a critical question: how do you maintain speed, clarity, and quality without adding friction?

In our latest tech blog by Derrick Tsorme, we explore how we’re rethinking support, moving from reactive, ticket-based workflows to a more intelligent, real-time system that surfaces answers instantly.

When done well, tech support can strengthen trust, improve decision-making, and keep critical workflows moving without delay.

This is part of a broader shift in how we build, with a strong focus on:
🔹 Reducing noise and fragmentation
🔹 Embedding knowledge directly into workflows
🔹 Enabling teams to act with speed and context

As with everything we create, the goal is simple: systems that work better under pressure, and scale without breaking.

Read the full blog at the link in our bio.

03/04/2026

This month, team Axmed is heading to Nairobi 🇰🇪

Our leadership team will be on the ground for a packed agenda, including our sponsorship of the International Maternal Newborn Health Conference (IMNHC).

Alongside the conference, we’re hosting an exclusive discussion with pharmaceutical manufacturers, procurers, and government stakeholders on Reshaping the Medicines Access and Supply Landscape in Kenya.

🗓️ March 23 | 8:00 - 10:00 AM

The discussion will cover:
👉 How technology-enabled procurement is transforming the affordability, reliability, and scale of access to health products
👉 What’s working in practice
👉 What comes next for strengthening health systems across the region

If you’re a manufacturer, procurer, or government stakeholder working within Kenya’s health ecosystem, we invite you to apply to attend.

Space is limited. Register your interest at the link in our bio.

Location details will be shared upon confirmation.

For questions, please drop us a message or get in touch at events@axmed.com.

02/26/2026

In Sub-Saharan Africa, postpartum haemorrhage (PPH) remains the leading cause of maternal death. In far too many delivery rooms, health workers still rely on visual estimates of blood loss - a method that leaves critical decisions up to chance when every second counts.

The calibrated obstetric drape changes that. This simple but powerful innovation, the drape provides an immediate, accurate measurement of blood loss - helping providers to detect PPH early and respond with speed and certainty.

Through our partnership with Sinapi Biomedical, we are delivering 600,000 drapes to an East African government, supporting a nationwide shift in how PPH is diagnosed and managed. 

Together, Sinapi and Axmed are making it possible for tools like this to reach the facilities that need them most. Because quality care shouldn’t depend on geography.

We’re just getting started.

02/24/2026

One week on.

The news of our $6M grant funding from the Gates Foundation to expand access to affordable, high-quality medicines across more markets and therapeutic areas has sparked global conversation and real momentum.

In just seven days, our announcement has been featured in 570+ media outlets, reaching a potential audience of 72 million across global health, finance, and innovation communities.

From the importance of localized procurement models to the future of global supply chain infrastructure, the coverage reflects what this moment represents: growing recognition that building better systems for medicine access is not only possible, it is urgent.

📰 Swipe to see some of the coverage highlights

🔗 Read the full release at the link in our bio.

02/19/2026

What happens when AI stops being a side tool and starts shaping how product teams actually plan, think, and build?

In this month’s Tech Blog, Anaman, Senior Product Manager, and Albergante, CTO at Axmed, explore how agent-driven workflows are changing the way we approach product planning - moving beyond static roadmaps and into a more contextual, collaborative way of working.

It’s an evolution that is taking teams from simply copy/pasting into chatbots to AI agents embedded in real workflows, connecting directly to internal codebases and Jira tickets.

The result is stronger planning, faster ex*****on, and decisions grounded in real system context. 🧠

Read now at the link in our bio.

02/17/2026

We’re proud to announce that Axmed has secured $6 million in non-dilutive grant funding from the Gates Foundation to scale our global infrastructure for medicine access.

The grant builds on the Foundation’s prior $5 million support and reflects continued conviction in Axmed’s ex*****on and operating model. With additional backing from Founderful Ventures, the company has now raised a total of $𝟏𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 in capital to date.

Since launch, we’ve built the world’s first geo-agnostic pooled procurement and integrated logistics platform purpose-built for low-and middle-income countries (LMICs). In just the last year, the Axmed platform:

🔹 Delivered 1,800+ metric tons of medicines and health supplies
🔹 Reached over 4.2 million people, up from 750,000 in 2024
🔹 Achieved 12x growth in annualized revenue year-on-year
🔹 Enabled average cost savings of 30–35% through demand aggregation and price transparency
🔹 Achieved a 70% repeat purchase rate, underscoring strong product-market fit and sustained buyer trust

The new funding will accelerate Axmed’s expansion across Africa and support procurement programs spanning multiple therapeutic areas, including family planning and malaria products serving mothers, children, and underserved patient populations across LMICs over the next 12 to 18 months.

Our ambition: reach 20+ countries by the end of 2026, serve 50+ million people within three years, and 100+ million by year five.

At its core, this is about more than growth. It’s about disciplined ex*****on at scale, strengthening the procurement systems and infrastructure that health systems need to deliver high-quality, affordable medicines to the people who need them most.

To the Gates Foundation, thank you for your continued partnership. To all those working to close the access gap: we’re with you.

📣 Read the full release at the link in our bio.

01/27/2026

Access to Medicines Will Be Won or Lost on How Markets Are Built

There is a persistent misconception in global health: that expanding access to medicines requires sacrificing commercial viability. That impact and returns sit in opposition to one another.

This framing is outdated, and it continues to slow real progress at the moment it is most needed.

Low- and middle-income countries (LMICs) account for over 85% of the world’s population and nearly 90% of the global disease burden, yet they represent less than 6% of global pharmaceutical revenue.

This imbalance is not a mystery. It is the logical outcome of markets designed without LMICs in mind. It is the architecture of the market itself.

Read more from our Co-Founder and Chief Commercial Officer Felix Ohnmacht in his latest article, Access to Medicines Will Be Won or Lost on How Markets Are Built, which argues that the future of access will be shaped by business models that treat LMICs as essential markets, and embed efficiency, transparency, and sustainability into how they function.

👉 Read the full piece: https://lnkd.in/eYNjpNiA

01/23/2026

If we want resilient health systems, procurement can no longer remain invisible.

Mattia Albergante, CTO at Axmed, argues that while conversations around AI advancement tend to focus on diagnostics and drug discovery, procurement is an often-overlooked area in keen need of an innovation overhaul.

Fragmentation and manual processes in procurement are quietly undermining impact, with thousands of procurement units, hospitals, and pharmacies continuing to operate in isolation.

AI, he argues, provides a real opportunity to make an impact.

👉 Read the full piece here: https://medium.com//procurement-as-the-invisible-bottleneck-in-global-health-deba5b92b4cb

Address

Boston, MA

Website

https://www.axmed.com/

Alerts

Be the first to know and let us send you an email when Axmed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Boston?